C2-AI, a Cambridge-based global leader in healthcare AI, delivers a service that seamlessly offers in-depth operational and clinical performance insights into, surgery, general medicine, and maternal & neonatal services. Their solutions help hospitals, health systems, and regulators understand and improve patient safety and clinical and financial performance, all without requiring integration with current systems. C2-Ai is adopted by the NHS in multiple ICBs and Trusts for waiting list risk stratification and prioritisation. Backed by over 300 publications, clinical trials, and 30 years of research, the companies unique AI engine, CRAB (Clinical Risk Adjustment and Benchmarking), is continuously updated. It's trained on the records of over 450 million patients providing unique, outcome-improving insights for patients, providers, and payers alike.